Suchergebnisse - "Kawakami, Hisato"

PubPharm (207)

1

New therapeutic target molecules for gastric and gastroesophageal junction cancer

enthalten in: International journal of clinical oncology | 2024

von Kawakami, H.

2

Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab : Results from the Gastric Cancer Cohort

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Kawazoe, A. | Yamamoto, N. | Sugimoto, N. | +17

3

Clinical practice guidelines for esophagogastric junction cancer : Upper GI Oncology Summit 2023

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2024

von Kitagawa, Y. | Matsuda, S. | Gotoda, T. | +60

4

Anti-integrin αvβ6 autoantibodies are a potential biomarker for ulcerative colitis-like immune checkpoint inhibitor-induced colitis

enthalten in: British journal of cancer | 2024

von Yokode, M. | Shiokawa, M. | Kawakami, H. | +28

5

Trifluridine/Tipiracil Plus Bevacizumab for Vulnerable Patients With Pretreated Metastatic Colorectal Cancer : A Retrospective Study (WJOG14520G)

enthalten in: The oncologist | 2024

von Kito, Y. | Kawakami, H. | Mitani, S. | +16

6

Clinical practice guidelines for esophagogastric junction cancer: Upper GI Oncology Summit 2023

enthalten in: Gastric cancer | 2024

von Kitagawa, Y. | Matsuda, S. | Gotoda, T. | +60

7

Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab : Results from the Small Cell Lung Cancer Cohort

enthalten in: Cancer research communications | 2024

von Nishio, M. | Murakami, S. | Kawakami, H. | +17

8

Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study : A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer

enthalten in: Targeted oncology | 2024

von Sunakawa, Y. | Kuboki, Y. | Watanabe, J. | +21

9

Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902)

enthalten in: International journal of clinical oncology | 2024

von Kawase, T. | Imamura, H. | Kawabata, R. | +11

10

Meta-analysis of three randomized trials of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as first-line treatment for advanced gastric cancer

enthalten in: International journal of clinical oncology | 2023

von Nishikawa, K. | Kawakami, H. | Shimokawa, T. | +11

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[21]